Friday 14^th November 2014

13:45      Welcome and Introduction (D. Betticher, Fribourg/M. Ghielmini, Bellinzona)

How should double-hit lymphomas be treated?

14:00      Clinical case (L. de Leval / J.-P. Zurcher)

14:10      Clinical case (S. Dirnhofer / F. Krasniqi)

14:20      Lecture (P. Johnson, Southampton)

14:50      Open discussion

Is there anything like indolent Mantle Cell lymphoma?

15:00      Clinical case (L. de Leval / J.-P. Zurcher)

15:10      Clinical case (S. Dirnhofer / F. Krasniqi)

15:20      Lecture (M. Ghielmini, Bellinzona)

15:50      Open discussion

16:00      Coffee break

Has interim PET any clinical consequence?

16:30      Clinical case (L. de Leval / J.-P. Zurcher)

16:40      Clinical case (S. Dirnhofer / F. Krasniqi)

16:50      Lecture (M. Meignan, Creteil)

17:20      Open discussion

When should residual disease be irradiated?

17:30      Clinical case (L. de Leval / J.-P. Zurcher)

17:40      Clinical case (S. Dirnhofer / F. Krasniqi)

17:50      Lecture (L. Specht, Copenhagen)

18:20      Open discussion

18:30      Adjourn

Saturday 15^th November 2014

Should BEACOPPesk still be used, and when?

08:00      Clinical case (L. de Leval / J.-P. Zurcher)

08:10      Clinical case (S. Dirnhofer / F. Krasniqi)

08:20      Lecture (A. Lohri, Basel)

08:50      Open discussion

What to do with antibiotic-resistant gastic MALT and non-gastic MALT cases?

09:00      Clinical case (L. de Leval / J.-P. Zurcher)

09:10      Clinical case (S. Dirnhofer / F. Krasniqi)

09:20      Lecture (E. Zucca, Bellinzona)

09:50      Open discussion

10:00      Coffee break

How should 17p- CLL be treated?

10:30      Clinical case (L. de Leval / J.-P. Zurcher)

10:40      Clinical case (S. Dirnhofer / F. Krasniqi)

10:50      Lecture (M. Gregor, Luzern)

11:20      Open discussion

Which are the new therapeutic agents and how will they enter clinical practice?

11:30      Clinical case (L. de Leval / J.-P. Zurcher)

11:40      Clinical case (S. Dirnhofer / F. Krasniqi)

11:50      Lecture (E. Zucca, Bellinzona)

12:20      Open discussion

12:30      Conclusions and evaluation

13:00      End